KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Invested Capital (2018 - 2025)

BioNTech SE's Invested Capital history spans 8 years, with the latest figure at $409.4 million for Q4 2025.

  • On a quarterly basis, Invested Capital changed N/A to $409.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 195.58% increase, with the full-year FY2025 number at $397.4 million, changed N/A from a year prior.
  • Invested Capital hit $409.4 million in Q4 2025 for BioNTech SE, down from $698.4 million in the prior quarter.
  • Over the last five years, Invested Capital for BNTX hit a ceiling of $15.5 billion in Q4 2021 and a floor of $6.2 million in Q4 2022.
  • Historically, Invested Capital has averaged $2.0 billion across 5 years, with a median of $373.6 million in 2021.
  • Biggest five-year swings in Invested Capital: crashed 99.96% in 2022 and later soared 838.43% in 2023.
  • Tracing BNTX's Invested Capital over 5 years: stood at $15.5 billion in 2021, then crashed by 99.96% to $6.2 million in 2022, then skyrocketed by 5525.29% to $350.1 million in 2023, then decreased by 24.21% to $265.3 million in 2024, then soared by 54.3% to $409.4 million in 2025.
  • Business Quant data shows Invested Capital for BNTX at $409.4 million in Q4 2025, $698.4 million in Q3 2025, and $164.1 million in Q2 2025.